Lisha Zhuang

State Key Laboratory Of Oncology In South China And Guangdong Provincial Clinical Research Center For Cancer
Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Extracellular vesicles from obese visceral adipose promote pancreatic cancer development and resistance to immune checkpoint blockade therapy.

Extracellular vesicles from obese visceral adipose promote pancreatic cancer development and resistance to immune checkpoint blockade therapy.

Journal: Cell metabolism

Published: April 04, 2025

CSTF2-impeded innate αβ T cell infiltration and activation exacerbate immune evasion of pancreatic cancer.

CSTF2-impeded innate αβ T cell infiltration and activation exacerbate immune evasion of pancreatic cancer.

Journal: Cell death and differentiation

Published: August 01, 2024

Psychological stress-induced ALKBH5 deficiency promotes tumour innervation and pancreatic cancer via extracellular vesicle transfer of RNA.

Psychological stress-induced ALKBH5 deficiency promotes tumour innervation and pancreatic cancer via extracellular vesicle transfer of RNA.

Journal: Nature cell biology

Published: May 09, 2024

KHSRP Stabilizes m6A-Modified Transcripts to Activate FAK Signaling and Promote Pancreatic Ductal Adenocarcinoma Progression.

KHSRP Stabilizes m6A-Modified Transcripts to Activate FAK Signaling and Promote Pancreatic Ductal Adenocarcinoma Progression.

Journal: Cancer research

Published: March 19, 2024

Single-cell transcriptomic analysis deciphers heterogenous cancer stem-like cells in colorectal cancer and their organ-specific metastasis.

Single-cell transcriptomic analysis deciphers heterogenous cancer stem-like cells in colorectal cancer and their organ-specific metastasis.

Journal: Gut

Published: May 24, 2023

Super-enhancer RNA m6A promotes local chromatin accessibility and oncogene transcription in pancreatic ductal adenocarcinoma.

Super-enhancer RNA m6A promotes local chromatin accessibility and oncogene transcription in pancreatic ductal adenocarcinoma.

Journal: Nature genetics

Published: October 26, 2022

N 6-methyladenosine Modification of FZR1 mRNA Promotes Gemcitabine Resistance in Pancreatic Cancer.

N 6-methyladenosine Modification of FZR1 mRNA Promotes Gemcitabine Resistance in Pancreatic Cancer.

Journal: Cancer research

Published: October 21, 2022

LncRNA BCAN-AS1 stabilizes c-Myc via N6-methyladenosine-mediated binding with SNIP1 to promote pancreatic cancer.

LncRNA BCAN-AS1 stabilizes c-Myc via N6-methyladenosine-mediated binding with SNIP1 to promote pancreatic cancer.

Journal: Cell death and differentiation

Published: October 05, 2022

CSTF2 mediated mRNA N6-methyladenosine modification drives pancreatic ductal adenocarcinoma m6A subtypes.

CSTF2 mediated mRNA N6-methyladenosine modification drives pancreatic ductal adenocarcinoma m6A subtypes.

Journal: Nature communications

Published: May 04, 2022

Detection of piRNA-54265 in human serum: evidence and significance.

Detection of piRNA-54265 in human serum: evidence and significance.

Journal: Cancer communications (London, England)

Published: March 17, 2022

RNA m6A regulates transcription via DNA demethylation and chromatin accessibility.

RNA m6A regulates transcription via DNA demethylation and chromatin accessibility.

Journal: Nature genetics

Published: August 02, 2021

ATXN2-mediated translation of TNFR1 promotes esophageal squamous cell carcinoma via m6A-dependent manner.

ATXN2-mediated translation of TNFR1 promotes esophageal squamous cell carcinoma via m6A-dependent manner.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: June 29, 2021

Showing 1-12 of 18

Last Updated: 09/26/2026